Multilabel classification of disease prediction in patients presenting with dyspnea

Baarts, Justus; Giezendanner, Stéphanie; Lüthi-Corridori, Giorgia; Brändle, Michael; Dieterle, Thomas; Gabutti, Luca; Hammerer‐Lercher, Angelika; Harmatz, Paul; Henny-Fullin, Katja; Muser, Jürgen; Leibundgut, Gregor; Leuppi-Taegtmeyer, Anne; Marbet, Corinne Punsap; Schraner, C.; Leüppi, Jörg D.; Jaun, Fabienne

doi:10.1183/13993003.congress-2021.pa3447

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Acute asthma exacerbation is regularly seen in emergency departments (EDs) and is potentially life-threatening. Recent data of our Diagnostic workup, Epidemiology and Causes Of DyspnEa (DECODE) project show that 4.5% of all patients presenting at our ED in Cantonal Hospital of Baselland (KSBL) in 2014 suffered from asthma exacerbation [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Audit of Asthma Exacerbation Management in a Swiss General Hospital

Schnyder¹,

Lüthi-Corridori²,

Leuppi-Taegtmeyer³

et al. 2022

Respiration

Self Cite

View full text Add to dashboard Cite

Background: Adequate management is crucial to reduce symptoms, hospitalization, and relapses in patients with asthma. Hospitals often struggle to meet treatment guidelines, and no recent data for Switzerland are available. Objectives: The aim of the study was to audit the asthma exacerbation management in the Cantonal Hospital of Baselland in order to evaluate the level of compliance with guidelines in a narrative discussion. Method: The study design is a retrospective observational cohort study. We evaluated all adult patients presenting to the hospital with a physician-diagnosed asthma exacerbation in 2018 and 2019. The asthma management patients received was compared to the Swiss guidelines and the international GINA guidelines. Results: 160 patients were included (mean age: 50 years old, 57.5% female). SpO2 and heart rate were assessed at presentation in nearly all patients. Peak expiratory flow (PEF) was measured in only 14%. Adequate management of asthma exacerbation with inhaled bronchodilator medication in a combination of short-acting beta-agonists and short-acting anticholinergics was administered to 96% of the patients. Patients with severe symptoms received systemic glucocorticosteroids within 6 h in 55%. At discharge, a reliever medication was prescribed for 64% of the patients and 55% received a new or increased controller therapy with inhaled glucocorticosteroid (ICS). 49% of the patients had no follow-up organized. Conclusion: To increase the guideline conformity and quality of asthma exacerbation management, the severity should be better assessed, especially by routinely performing PEF measurements. Treatment needs to be intensified; in particular, the ICS dose should be increased significantly and systemic glucocorticosteroids should be given with a lower threshold.

show abstract

Section: Introductionmentioning

confidence: 99%